• Department of Thoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, P. R. China;
GE Mingjian, Email: mingjian_ge@hospital.cqmu.edu.cn
Export PDF Favorites Scan Get Citation

Objective To introduce a new method for identifying intersegmental planes during thoracoscopic segmentectomy using pulmonary circulation single-blocking in the target segment. Methods To retrospectively analyze the clinical data of 83 patients who underwent thoracoscopic pulmonary segmentectomy from January 2019 to March 2020 using the pulmonary circulation single-blocking method. There were 33 males and 50 females, with a median age of 54 (46-65) years, and they were divided into a single vein group (SVG, n=31) and a single artery group (SAG, n=52), and the clinical data of two groups were compared. Results The intersegmental planes were identified successfully in both groups and there were no statistically significant differences between the two groups in terms of intersegmental plane management (P=0.823), operating time (P=0.786), intraoperative blood loss (P=0.775), chest drainage time (P=0.659), postoperative hospital stay (P=0.824) or the incidence of postoperative complications (P=1.000). Conclusion The use of pulmonary circulation single-blocking for intersegmental plane identification during thoracoscopic segmentectomy is safe and feasible, and the intersegmental plane can be satisfactorily identified by the single-blocking of arteries or veins.

Citation: SUN Weijie, ZHANG Min, CHEN Xu, DENG Yuanlin, GE Mingjian. Application of pulmonary circulation single-blocking method in intersegmental plane identification during segmentectomy. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(1): 52-57. doi: 10.7507/1007-4848.202208030 Copy

  • Previous Article

    Diagnostic value of exosome miRNA-21 in bile for cholangiocarcinoma
  • Next Article

    Study on liver transplantation combined with adenovirus-mediated delivery of herpes simplex virus thymidine kinase/ganciclovir in treatment of hepatocellular carcinoma